02.11.2011 14:15:00

Versar Inc. Awarded GSA Professional Engineering Services (PES) Schedule

Versar, Inc. (NYSE AMEX: VSR) announced it has been awarded a General Services Administration (GSA) Professional Engineering Services (PES) Contract Schedule 871. The contract has a base period of performance of five (5) years, plus three (3) option periods of five (5) years each.

The PES contract was established by GSA to provide Federal, State, Local, and United Nations agencies with solutions for their various engineering requirements and allow those agencies to procure needed services. The comprehensive statement of work provides a streamlined approach to accessing qualified firms in the engineering disciplines of mechanical, electrical, chemical, components of civil engineering, and sub-disciplines such as aerospace, nuclear, bioengineering, fire protection, and marine architecture and expertise in construction management.

Tony Otten, CEO of Versar, Inc., said, "The GSA PES Schedule provides another important and widely accepted contract vehicle that will allow our government clients an efficient alternative for contracting engineering services at competitive rates.”

Mr. Otten continued, ”This award further supports a key initiative for Versar - providing technical services in harsh environments and continuing to support the United States government in our worldwide reconstruction efforts.”

VERSAR, INC., headquartered in Springfield, VA, is a publicly held global project management company providing sustainable solutions to government and commercial clients in construction management, environmental services, munitions response, telecommunications and energy. Versar operates a number of web sites, including the corporate Web sites, www.versar.com, www.homelanddefense.com, www.geomet.com; www.viap.com; www.dtaps.com; www.adventenv.com, and www.ppsgb.com.

This press release contains forward-looking information. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar’s Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended July 1, 2011, as updated from time to time in the Company’s periodic filings. The forward-looking statements are made as of the date hereof and Versar does not undertake to update its forward-looking statements.

Nachrichten zu Corgenix Medical CorporationShsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Corgenix Medical CorporationShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!